Smith Salley Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-51,778
Closed -$2.92M 177
2014
Q3
$2.92M Buy
51,778
+2,926
+6% +$157K 0.78% 45
2014
Q2
$2.6M Buy
48,852
+8,320
+21% +$442K 0.69% 54
2014
Q1
$2.12M Buy
40,532
+160
+0.4% +$8.1K 1.32% 34
2013
Q4
$2.17M Buy
+40,372
New +$2.08M 1.41% 30

Other funds holding SNY

Smith Salley Wealth Management's SNY Position: Q4 2014 in Review

Smith Salley Wealth Management sold out of Sanofi (SNY) in Q4 2014, closing a stake of 51,778 shares — an estimated $2.92M sold.

Smith Salley Wealth Management first reported a position in SNY in Q4 2013 and held it in 4 quarters. The position peaked at $2.92M in Q3 2014. 499 funds tracked by Wall St. Rank hold SNY as of Q4 2014.

  • Smith Salley Wealth Management reported no remaining Sanofi position as of Q4 2014 after selling out during the quarter.
  • Smith Salley Wealth Management sold 51,778 Sanofi shares in Q4 2014, an estimated $2.92M.
  • Smith Salley Wealth Management first reported a position in Sanofi in Q4 2013 and held it in 4 quarters.
  • Smith Salley Wealth Management's Sanofi position peaked at $2.92M in Q3 2014.
  • 499 funds tracked by Wall St. Rank held Sanofi as of Q4 2014.

Based on Smith Salley Wealth Management's 13F filing for Q4 2014, filed 4 Feb 2015.